Patients should take the applesauce with sprinkled beads in its entirety without chewing. If the patient is using the sprinkle administration method, the sprinkled applesauce should be consumed immediately it should not be stored.
Titrate at weekly intervals to appropriate efficacy and tolerability as indicated.Īdderall XR extended release capsules may be taken whole, or the capsule may be opened and the entire contents sprinkled on applesauce. Administer Adderall XR at the lowest effective dosage.īased on bioequivalence data, patients taking divided doses of immediate-release ADDERALL, (for example, twice daily), may be switched to Adderall XR at the same total daily dose taken once daily. Individualize the dosage according to the therapeutic needs and response of the patient. Maintain careful prescription records, educate patients about abuse, monitor for signs for abuse and overdose, and periodically re-evaluate the need for Adderall XR use. Īssess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy. Prior to initiating treatment with Adderall XR, assess for the presence of cardiac disease (e.g., perform a careful history, family history of sudden death or ventricular arrhythmia, and physical exam). Adderall XR Dosage and Administration Important Information Prior to Initiating Treatment Therefore, the physician who elects to use Adderall XR for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient. The effectiveness of Adderall XR for long-term use, i.e., for more than 3 weeks in children and 4 weeks in adolescents and adults, has not been systematically evaluated in controlled trials. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. Appropriate educational placement is essential and psychosocial intervention is often helpful. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Drug treatment may not be indicated for all patients with this syndrome. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of DSM-IV ® characteristics.Īdderall XR is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Specific etiology of this syndrome is unknown, and there is no single diagnostic test. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming leaving seat inappropriate running/climbing difficulty with quiet activities "on the go " excessive talking blurting answers can't wait turn intrusive. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes lack of sustained attention poor listener failure to follow through on tasks poor organization avoids tasks requiring sustained mental effort loses things easily distracted forgetful. The symptoms must not be better accounted for by another mental disorder. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. Ī diagnosis of ADHD (DSM-IV ®) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years.
30mg adderall taken 7 hours before a physical for work trial#
The efficacy of Adderall XR in the treatment of ADHD was established on the basis of two controlled trials in children aged 6 to 12, one controlled trial in adolescents aged 13 to 17, and one controlled trial in adults who met DSM-IV ® criteria for ADHD. Indications and Usage for Adderall XR Attention Deficit Hyperactivity DisorderĪdderall XR ® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy. CNS stimulants, including Adderall XR, other amphetamine-containing products, and methylphenidate, have a high potential for abuse and dependence.